BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30930183)

  • 1. A multicentre evaluation of the Elecsys
    Jacobs MH; Reuter LM; Baker VL; Craig LB; Sakkas D; Surrey E; Doody KJ; Jungheim ES; Bayrak AB; Hund M; Verhagen-Kamerbeek WDJ; Pardue D; Buck K; Timm B
    Reprod Biomed Online; 2019 May; 38(5):845-852. PubMed ID: 30930183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa.
    Neves AR; Blockeel C; Griesinger G; Garcia-Velasco JA; Marca A; Rodriguez I; Drakopoulos P; Alvarez M; Tournaye H; Polyzos NP
    Reprod Biomed Online; 2020 Jul; 41(1):29-36. PubMed ID: 32466992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.
    Tadros T; Tarasconi B; Nassar J; Benhaim JL; Taieb J; Fanchin R
    Fertil Steril; 2016 Dec; 106(7):1800-1806. PubMed ID: 27692436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
    Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
    Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.
    Anderson RA; Anckaert E; Bosch E; Dewailly D; Dunlop CE; Fehr D; Nardo L; Smitz J; Tremellen K; Denk B; Geistanger A; Hund M
    Fertil Steril; 2015 Apr; 103(4):1074-1080.e4. PubMed ID: 25681853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of evaluative effectiveness between antral follicle count/age ratio and ovarian response prediction index for the ovarian reserve and response functions in infertile women.
    Zhou SJ; Zhao MJ; Li C; Su X
    Medicine (Baltimore); 2020 Sep; 99(36):e21979. PubMed ID: 32899038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
    Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
    J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
    Baker VL; Gracia C; Glassner MJ; Schnell VL; Doody K; Coddington CC; Shin SS; Marshall LA; Alper MM; Morales AJ; Pavone ME; Behera MA; Zbella EA; Shapiro BS; Straseski JA; Broyles DL
    Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Bas-Lando M; Rabinowitz R; Farkash R; Algur N; Rubinstein E; Schonberger O; Eldar-Geva T
    Gynecol Endocrinol; 2017 Oct; 33(10):797-800. PubMed ID: 28454495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which is more predictive ovarian sensitivity marker if there is discordance between serum anti-Müllerian hormone levels and antral follicle count? A retrospective analysis.
    Aslan K; Kasapoglu I; Cakir C; Koc M; Celenk MD; Ata B; Avci B; Uncu G
    J Obstet Gynaecol; 2022 Jul; 42(5):1461-1466. PubMed ID: 34996328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
    Hum Reprod; 2021 May; 36(6):1530-1541. PubMed ID: 33822057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic and Sociocultural Differences in Ovarian Reserve: Age-Specific Anti-Müllerian Hormone Values and Antral Follicle Count for Women of the Arabian Peninsula.
    Melado L; Vitorino R; Coughlan C; Bixio LD; Arnanz A; Elkhatib I; De Munck N; Fatemi HM; Lawrenz B
    Front Endocrinol (Lausanne); 2021; 12():735116. PubMed ID: 34745004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.